Case Studies Onexa

“I'm 60, my Carrosserie repair shop has five loyal employees, and I still don't have a successor.”

As a family business, you've never let anyone from outside take a real look at your numbers. But the margin erosion you can't quite explain and the succession question you keep pushing back both need the same thing first: an honest, external diagnosis — before the decision gets made for you.

“My daughter is taking over the business, but our customers can't tell us apart from the three competitors down the road.”

You've built the business on relationships and reputation for 25 years. But the next generation is inheriting a market that has become crowded and commoditized — and "we've always done good work" isn't a position, it's a hope.

“We take almost any project that comes our way — and I'm not sure anymore what we're actually best at.”

Growth built on saying yes to everything feels safe, until it isn't: margins get thinner, teams are stretched in too many directions, and nobody outside the company could explain in one sentence what you stand for.

“Everyone respects 'Swiss quality' — but that's not a strategy for expanding into Germany or France.”

You've proven the model at home. Now you need a market position that travels: one that says more than a passport stamp, and actually gives international customers a real reason to choose you over local players.

“Our exclusivity deal was our whole business model — now the manufacturer wants to go direct.”

You built 30 jobs around distributing someone else's premium generators. Losing exclusivity isn't a footnote, it's an existential strategy question — and you need a new market position before your biggest partner becomes your biggest competitor.

“Customers only ever ask us about the price — even though we know our product is better.”

Somewhere along the way, your premium started being treated like a commodity. That's rarely a product problem; it's usually a story problem — and fixing it means making your real advantage visible and impossible to price-shop.

“We used to be ahead. Now three cheaper competitors are doing '80% as good' and winning the deals.”

You still have the better engineering and the better service. What's missing is translating that edge into something customers immediately recognize as worth paying more for – before the market decides "good enough" is good enough.

“Everyone's talking about AI, and I don't even know where to start.”

“We grew 40% in two years, and now nothing runs the way it used to.”

“Half our operation still runs on spreadsheets, phone calls and someone's memory.”

“Our device works — but between clinical evidence, market access and regulatory approval, we don't know which door to open first.”

You don't need another generalist strategy firm; you need people who have actually walked this path. We bring hands-on life sciences and medtech expertise so decisions get made with confidence, not guesswork.

“We have a working prototype and eighteen months of runway — and we still haven't decided which market to enter first.”

Regulatory pathway, reimbursement landscape and clinical evidence requirements all look different depending on where you launch. Getting this sequence wrong doesn't just cost time — for a startup, it can cost the company.

“MDR compliance is eating our roadmap, and I'm worried we'll run out of R&D capacity before we run out of paperwork.”

The regulatory burden is real, but it doesn't have to freeze your pipeline. What you need is a way to meet the requirements without putting your actual innovation on hold indefinitely. 

“We know our product needs to evolve, but every internal workshop ends in the same debate.”

Your team has the expertise — what's missing is a neutral facilitator who can break old patterns, structure the discussion and turn two days in a room into a roadmap everyone actually commits to. 

“Leadership is aligned on where we're going. The rest of the organization isn't.”

A strategy that only lives in the boardroom isn't a strategy yet — it's an intention. Turning it into results means staying in the room long enough to get middle management and frontline teams pulling in the same direction.

“We bought a new CRM eight months ago. Half the team still uses the old system — or nothing at all.”

New tools don't fix old habits by themselves. Without someone driving adoption through the awkward middle phase, expensive systems quietly become expensive shelfware.